NLRP3 gain-of-function mutation results in excessive release of IL-1β, giving rise to cryopyrin-associated periodic syndrome (CAPS), a group of rare hereditary autoinflammatory diseases [4]. This evidence concerns the gene IL1B and cryopyrin-associated periodic syndrome.